Comparison of St John's wort and imipramine for treating depression: Randomised controlled trial

British Medical Journal

Volumn 321, Issue 7260, 2000, Pages 536-539

  Woelk, Helmut ^a  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

IMIPRAMINE;

ADULT; ANXIETY; ARTICLE; ASTHENIA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DRUG EFFECT; DRUG EFFICACY; DRUG TOLERABILITY; DRUG TOLERANCE; FEMALE; HAMILTON SCALE; HEADACHE; HUMAN; HYPERICUM PERFORATUM; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NAUSEA; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; RANDOMIZED CONTROLLED TRIAL; SWEATING; TREATMENT OUTCOME; VERTIGO; XEROSTOMIA;

EID: 0034596545     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.321.7260.536     Document Type: Article

References (27)

1. 1 Fernie WT. Herbal simples. Bristol:John Wright, 1897.
2. 2 Pratt A. Wild flowers. London: Society for Promoting Christian Knowledge. 1853.
3. 3 Pickering C. Chronological history of plants. Boston: Little Brown, 1879.
4. 4 Commission Nationale de Pharmacopée France. Pharmacopée française. 10th ed. Paris: Adrapharm, 1982.
5. 5 Kommissio Deutscher Arzneimittel-Codex. Johanniskraut-Hyperici herba. DAC 1986.
6. 6 Linde K, Ramirez G, Mulrow C D, Pauls A, Weidenhammer W, Melchart D. St John's wort for depression-an overview and meta-analysis of randomised clinical trials. BMJ 1996;313:253-8.
7. 7 Wheatley D. LI160, an extract of St John's wort versus amitriptyline in mildly to moderately depressed outpatients - a controlled 6-week clinical trial. Pharmacopsychiatry 1997;30(suppl):77-80.
8. 8 Vorbach EU, Hübner WD, Arnoldt KH. Effectiveness and tolerance of the hypericum extract LI160 in comparison with imipramine: randomised double-blind study in 135 outpatients. J Geriat Psychiatry Neurol 1994;7(suppl 1):19-23S.
9. 9 Hansgen KD, Vesper J, Ploch M. Multicentre double-blind study examining the antidepressant effectiveness of the hypericum extract LI160. J Geriat Psychiatry Neurol 1994;7(suppl 1):15-8S.
10. 10 Witte B, Harrer G, Kaplan T, Podzuweit H, Schmidt U. Treatment of depression with a highly concentrated hypericum preparation: a multicentre, placebo-controlled, double-blind study. Fortschr Med 1995;113:404-8.
11. 11 Schrader E, Meier B, Brattström A. Hypericum treatment of mild-moderate depression in a placebo-controlled study. A prospective, double-blind, randomized, placebo-controlled, multicentre study. Hum Psychopharmacol 1998;13:163-9.
12. 12 Harrer C, Hübner WD, Podzuweit H. Effectiveness and tolerance of the hypericum extract LI160 compared with maprotiline: a multicentre double-blind study. J Geriat Psychiatry Neurol 1994;7(suppl 1):24-8S.
13. 13 Vorbach EU, Arnoldt KH, Hübner WD. Efficacy and tolerability of St John's wort extract LI160 versus imipramine in patients with severe depressive episodes according to ICD10. Pharmacopsychiatry 1997;30(suppl):81-3.
14. 14 Ernst E. St John's wort as antidepressive therapy. Fortschr Med 1995;113:354-5.
15. 15 Angst J, Bech P, Boyer P, Bruinvels J, Engel R, Helmchen H. Consensus on the methodology of clinical trials of antidepressants, Zurich, March 1988: report of the Consensus Committee. Pharmacopsychiatry 1989;22:3-7.
16. 16 International Conference on Harmonisation, Committee on Proprietary Medicinal Products. Notes for guidance on good clinical practice. London: European Agency for Evaluation of Medicinal Products, 1997. (ICH/135/95.)
17. 17 European Union. Good clinical practice for clinical investigation of medicines in the European Community. Vol 3. London: European Agency for Evaluation of Medicinal Products, 1996:115-32.
18. 18 Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960;23:56-62.
19. 19 Hamilton M. Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol 1967:6:278-96.
20. 20 National Institute of Mental Health. 028 CGI clinical global impressions. In: Guy W, ed. ECD-EC assessment for psychopharmacology. Rev ed. Rockville, MD: National Institute of Mental Health, 1976:217-22.
21. 21 Jones B, Jarvis P, Lewis JA, Ebbutt AF. Trials to assess equivalence: the importance of rigorous methods. BMJ 1996;313;36-9.
22. 22 DeSmet PA, Molen WA. St John's wort as an antidepressant. BMJ 1996;313:211-2.
23. 23 Philipp M, Kohnen R, Hiller KO. Hypericum extract versus imipramine or placebo in patients with moderate depression: randomised multicentre study of treatment for eight weeks. BMJ 1999;319:1534-8.
24. 24 Ruschitzka F, Meier PJ, Turina M, Luescher TF, Noll G. Acute heart transplant rejection due to St John's wort. Lancet 2000;355:548-9.
25. 25 Johne A, Brockmöller J. Bauer S, Maurer A, Langheinrich M, Roots I. Pharmacokinetic interaction of digoxin with an herbal extract from St. John's wort (Hypericum perforatum). Clin Pharmacol Ther 1999;66:338-45.
26. 26 Piscitelli SC, Burstein AH, Chaitt D, Alfano RM, Falloon J. Indinavir concentrations and St John's wort. Lancet 2000;355:547-8.
27. 27 Nebel A, Schneider BJ, Baker RK, Kroll DJ. Potential metabolic interaction between St. John's wort and theophylline. Ann Pharmacother 1999;33:502.